Clinical Trials Logo

Clinical Trial Summary

Individuals with dry mouth (a reduction in the production of saliva) suffer from high rates of oral diseases. Dry mouth is a common problem among older individuals, because many medications to control chronic conditions (such as blood pressure, bladder-control problems and depression) reduce the flow of saliva. For these individuals, fluoride is used to maintain a good oral health. Usually, higher fluoride concentration products, such as prescription toothpastes, are recommended. In this project, the ability to increase fluoride retention in the mouth by using calcium before a conventional fluoride rinse will be tested in older adults with a range of salivary flow rates. This approach was never tested in patients with dry mouth, for whom the treatment with calcium may also be beneficial. A crossover, clinical study with two experimental phases will be conducted, in which patients with a range of saliva flows (from normal to dry mouth) will rinse with a fluoride rinse only (used at over the counter concentration), or a fluoride rinse preceded by a calcium rinse. The concentration of fluoride and calcium in the saliva and dental plaque residues will be determined up to two hours after the rinse(s), to test the effect of the approach to optimize fluoride retention in the mouth of patients with dry mouth.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04239872
Study type Interventional
Source University of Michigan
Contact
Status Completed
Phase Phase 1
Start date March 11, 2020
Completion date April 5, 2021

See also
  Status Clinical Trial Phase
Completed NCT03302676 - The Use of Chewing Gum for Xerostomia and Hyposalivation After Radiotherapy for Oral and Oropharyngeal Tumors N/A
Not yet recruiting NCT04323384 - The Effect of Biotene® on the Symptoms of Xerostomia and Mastication and Swallowing N/A
Completed NCT02677480 - The Effect of Probiotic Streptococci and pH-rising Components on the Oral Microbial Flora Phase 1
Completed NCT03049943 - Low Level Laser Therapy for Hyposalivation N/A
Active, not recruiting NCT03874572 - Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth Phase 1
Recruiting NCT05242991 - Effectiveness of Photobiomodulation Protocols in Radiation-induced Oral Side Effects in H&N Cancer Patients N/A
Terminated NCT03601962 - Effects of Aqualief® in Patients With Xerostomia as Consequence of Radiotherapy for Head and Neck Cancer N/A
Recruiting NCT03435328 - Hyposalivation Response To Transcutaneous Electrical Nerve Stimulation In Diabetic Type 2 Patients N/A
Completed NCT02049112 - A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study Phase 4
Terminated NCT01165970 - Effect of Saliva Substitutes on Dental Hard Tissues in Situ Phase 2/Phase 3
Completed NCT00426543 - Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome Phase 2
Recruiting NCT05759975 - Effectiveness of Extraoral Photobiomodulation in Management of Oral Adverse Effects in Patients Undergoing HSCT N/A
Completed NCT03578900 - Quality of Life and Sjögren Syndrome Phase 4
Completed NCT04717765 - Photobiomodulation in Oral Lesions Resulting From Anti-neoplastic Prevention N/A
Completed NCT03151889 - Eletric Stimulation for Hipossalivation Induced by Radiotherapy N/A
Enrolling by invitation NCT03876197 - Mesenchymal Stem Cells for Radiation-induced Xerostomia Phase 1/Phase 2